4519
JP:CO:CHUGAI-PHARM
CHUGAI PHARMACEUTICAL CO., LTD.
- Stock
Last Close
6,383.00
22/11 06:45
Market Cap
10.45T
Beta: -
Volume Today
2.47M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 100.96B - | 99.05B 1.89% | 110.16B 11.22% | 102.80B 6.68% | 124.78B 21.38% | 151.86B 21.70% | 249.50B 64.30% | 340.23B 36.36% | 470.37B 38.25% | 575.88B 22.43% | 325.47B 43.48% | |
depreciation and amortization | 14.49B - | 14.88B 2.69% | 15.57B 4.62% | 16.37B 5.15% | 16.33B 0.21% | 26.40B - | 30.48B 15.44% | 30.87B 1.29% | 31.43B 1.83% | 31.74B 0.97% | ||
deferred income tax | ||||||||||||
stock based compensation | ||||||||||||
change in working capital | -19.66B - | -33.30B 69.39% | -15.95B 52.12% | -36.16B 126.77% | 14.46B 140.00% | 4.49B 68.99% | 6.21B 38.32% | -64.42B 1,138.21% | -83.12B 29.03% | -183.31B 120.53% | 130.63B 171.26% | |
accounts receivables | ||||||||||||
inventory | ||||||||||||
accounts payables | ||||||||||||
other working capital | 6.21B - | -64.42B 1,138.21% | -83.12B 29.03% | -183.31B 120.53% | 130.63B 171.26% | |||||||
other non cash items | -42.27B - | -43.59B 3.14% | -46.86B 7.50% | -44.22B 5.64% | -47.95B 8.44% | -37.27B 22.28% | -75.47B 102.49% | -101.25B 34.17% | -138.49B 36.78% | -179.89B 29.89% | -76.52B 57.46% | |
net cash provided by operating activities | 53.52B - | 37.03B 30.80% | 62.92B 69.89% | 38.79B 38.35% | 107.62B 177.47% | 119.07B 10.64% | 206.64B 73.54% | 205.03B 0.78% | 279.63B 36.38% | 244.11B 12.70% | 411.33B 68.50% | |
investments in property plant and equipment | -14.96B - | -19.17B 28.09% | -25.26B 31.80% | -36.42B 44.17% | -44.53B 22.25% | -77.67B 74.44% | -61.18B 21.24% | -61.41B 0.38% | -72.87B 18.65% | -71.24B 2.23% | -74.26B 4.24% | |
acquisitions net | -2.96B - | -1.65B 44.19% | -6.12B 270.50% | -5.95B 2.80% | -10.86B 82.61% | 5.89B 154.21% | 8.17B 38.77% | 4.35B 46.76% | 6.90B 58.59% | 1.05B 84.80% | 19.35B 1,745.99% | |
purchases of investments | -240.86B - | -228.29B 5.22% | -241.43B 5.76% | -208.69B 13.56% | -208.48B 0.10% | -264.21B 26.73% | -257.78B 2.43% | -248.32B 3.67% | -372.26B 49.91% | -519.00B 39.42% | -545.98B 5.20% | |
sales maturities of investments | 242.20B - | 231.87B 4.26% | 221.68B 4.40% | 234.70B 5.87% | 215.51B 8.18% | 267.57B 24.16% | 236.90B 11.46% | 211.32B 10.80% | 325.03B 53.81% | 442.92B 36.27% | 546.96B 23.49% | |
other investing activites | 3.37B - | 2.89B 14.39% | 5.86B 103.19% | 6.25B 6.58% | 11.64B 86.18% | -5.64B 148.44% | -7.85B 39.29% | -4.25B 45.89% | -5.72B 34.67% | 280M 104.89% | 15.16B 5,314.64% | |
net cash used for investing activites | -13.21B - | -14.35B 8.61% | -45.27B 215.44% | -10.11B 77.67% | -36.72B 263.29% | -74.06B 101.70% | -81.74B 10.37% | -98.31B 20.27% | -118.93B 20.97% | -145.99B 22.76% | -38.77B 73.44% | |
debt repayment | -994M - | -968M 2.62% | -1.11B - | -949M 14.73% | -796M 16.12% | -8.89B 1,016.58% | -8.47B 4.75% | -9.08B 7.24% | ||||
common stock issued | 820M - | 1.23B 49.51% | 1.41B 14.68% | 506M 64.01% | 922M 82.21% | 996M 8.03% | 735M 26.20% | 440M 40.14% | 322M 26.82% | 241M 25.16% | 217M 9.96% | |
common stock repurchased | -12M - | -19M 58.33% | -7M - | -20M 185.71% | -19M 5% | -25M 31.58% | -30M 20% | -8M 73.33% | -5M 37.50% | -5M 0% | ||
dividends paid | -22.87B - | -24.52B 7.20% | -28.38B 15.72% | -31.68B 11.64% | -30.05B 5.12% | -35.01B 16.49% | -56.37B 61.01% | -91.44B 62.22% | -98.64B 7.88% | -138.22B 40.12% | -131.59B 4.79% | |
other financing activites | -109M - | -107M 1.83% | -1.50B 1,300% | -1.12B 24.97% | 538M 147.86% | -185M 134.39% | -2.32B 1,156.22% | 1M 100.04% | 1M 0% | -7.66B 765,800% | -7.87B 2.76% | |
net cash used provided by financing activities | -23.17B - | -24.39B 5.26% | -28.47B 16.73% | -33.41B 17.38% | -29.56B 11.53% | -35.01B 18.44% | -66.87B 90.99% | -99.50B 48.79% | -107.41B 7.95% | -145.64B 35.60% | -139.25B 4.39% | |
effect of forex changes on cash | 2.49B - | 673M 72.93% | -1.51B 324.81% | -1.60B 6.01% | 2.36B 247.32% | -2.21B 193.74% | -947M 57.25% | 1.17B 223.13% | 2.13B 82.50% | 1.94B 8.88% | 3.20B 65.09% | |
net change in cash | 19.63B - | -1.03B 105.26% | -12.33B 1,093.61% | -6.34B 48.59% | 43.71B 789.48% | 7.79B 82.19% | 57.08B 633.12% | 8.39B 85.30% | 55.42B 560.39% | -45.58B 182.25% | 236.50B 618.83% | |
cash at beginning of period | 95.44B - | 115.07B 20.56% | 114.04B 0.90% | 101.71B 10.81% | 95.37B 6.23% | 139.07B 45.83% | 146.86B 5.60% | 203.94B 38.87% | 212.33B 4.11% | 267.75B 26.10% | 222.17B 17.02% | |
cash at end of period | 115.07B - | 114.04B 0.90% | 101.71B 10.81% | 95.37B 6.23% | 139.07B 45.83% | 146.86B 5.60% | 203.94B 38.87% | 212.33B 4.11% | 267.75B 26.10% | 222.17B 17.02% | 458.67B 106.45% | |
operating cash flow | 53.52B - | 37.03B 30.80% | 62.92B 69.89% | 38.79B 38.35% | 107.62B 177.47% | 119.07B 10.64% | 206.64B 73.54% | 205.03B 0.78% | 279.63B 36.38% | 244.11B 12.70% | 411.33B 68.50% | |
capital expenditure | -14.96B - | -19.17B 28.09% | -25.26B 31.80% | -36.42B 44.17% | -44.53B 22.25% | -77.67B 74.44% | -61.18B 21.24% | -61.41B 0.38% | -72.87B 18.65% | -71.24B 2.23% | -74.26B 4.24% | |
free cash flow | 38.56B - | 17.87B 53.66% | 37.66B 110.75% | 2.37B 93.72% | 63.10B 2,567.95% | 41.40B 34.38% | 145.46B 251.34% | 143.62B 1.26% | 206.76B 43.96% | 172.87B 16.39% | 337.07B 94.98% |
All numbers in (except ratios and percentages)